Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1411237Generated: October 31, 2026

Formic Acid → 5-bromo-N-(5-chlorothiazol-2-yl)-1'-formylspiro[indoline-3,3'-pyrrolidine]-1-carboxamide

https://huagongshe.com/reaction/1411237

Reaction equation

Participants

RoleNameHCIDCharge
ReactantFormic AcidHCID 284—
Reactant1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
ReactantHCID 71522964HCID 71522964—
SolventWaterHCID 962—
SolventDimethylformamideHCID 6228—
Product5-bromo-N-(5-chlorothiazol-2-yl)-1'-formylspiro[indoline-3,3'-pyrrolidine]-1-carboxamideHCID 9044985054.3%

Reaction Steps

The 5-bromo-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3′-pyrrolidine]-1-carboxamide (160 mg, 0.387 mmol) obtained in Example 2 was dissolved in N,N′-dimethylformamide (4.0 mL). Thereafter, formic acid (22.0 μL, 0.581 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (148 mg, 0.774 mmol) were added to the above obtained solution, and the thus obtained mixture was then stirred for 18 hours. Thereafter, the reaction solution was diluted with water, and was then extracted with ethyl acetate. The organic layer was washed with brine, and was then dried over anhydrous sodium sulfate, followed by concentration in vacuo. The obtained residue was purified by silica gel column chromatography (chloroform:methanol=20:1) to obtain the captioned compound (92.8 mg, 54%) in the form of a white solid.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08921576B2
Source datasetuspto-grants-2014_12
ORD IDord-21f70541b70c4beda3145e39294aec67
Source noteuspto-grants-2014_12